MNKD Q1 2021 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+7.4% YoY

Gross Profit

$10M56.4% margin

Operating Income

-$6M-35.5% margin

Net Income

-$13M-74.1% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$319M

Total Liabilities

$493M

Stockholders' Equity

-$174M

Cash & Equivalents

$248M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$16M	+7.4%
Gross Profit	$10M	$9M	+12.8%
Operating Income	-$6M	-$7M	+13.1%
Net Income	-$13M	-$9M	-38.6%

Revenue Segments

License And Service

$3M100%